Диагностика и тактика ведения пациентов с полипами желудка (литературный обзор)
Обзорная статья
Дата публикации: июня 11, 2019
Ключевые слова
полипы желудка
H. pylori
polyps
H. pylori
polyps
Как цитировать
[1]
Н. Н. Голубев и Е. Г. Бурдина, Диагностика и тактика ведения пациентов с полипами желудка (литературный обзор), КМКВ, вып. 2, сс. 51-58, июн. 2019.
Аннотация
В обзоре представлены современные данные по основным видам полипов желудка. Большое внимание уделено клинико-эндоскопическим аспектам их диагностики. Рассмотрена классификация неэпителиальных и эпителиальных полипов желудка. Обсуждается тактика ведения пациентов с различными типами полиповЛитература
1. Park DY, Lauwers GY. Gastric Polyps: classification and management. Arch. Pathol. Lab. Med. 2008; 132(4): 633-640. doi: 10.1043/1543-2165(2008)132[633:GPCAM]2.0.CO;2.
2. Carmack SW, Genta RM, Graham DY, Lauwers GY. Management of gastric polyps: a pathologybased guide for gastroenterologists. Nat. Rev. Gastroenterol. Hepatol. 2009; 6(6): 331-341. doi: 10.1038/nrgastro.2009.70.
3. Yamada S, Ichikawa H. Endoscopic characteristics of epithelial gastric polyps. J Gastroenterol. 1966; 6(5): 132-654.
4. Goddard AF, Badreldin R, Pritchard DM, Walker MM, Warren B; British Society of Gastroenterology. The management of gastric polyps. Gut 2010; 59(9): 1270-1276. doi: 10.1136/gut.2009.182089.
5. Аруин Л.И., Капуллер Л.Л., Исаков В.А. Морфологическая диагностика болезней желудка и кишечника. М.: «Триада-Х»; 1998: 496 с.
6. Hiroyoshi O, Riddell R. Gastric Adenoma: Reclassification based on phenotypes and its clinical and diagnostic significance. Pathology case reviews. 2008; 13(5): 189-198. doi: 10.1097/PCR.0b013e318186ac12.
7. Vieth M, Kushima R, Borchard F, Stolte M. Pyloric gland adenoma: a clinicopathological analysis of 90 cases. Virchows Arch. 2003; 442(4): 317-321. doi: 10.1007/s00428-002-0750-6.
8. Abraham SC, Park SJ, Mugartegui L, Hamilton SR, Wu TT. Sporadic fundic gland polyps with epithelial dysplasia: evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Pathol. 2002; 161(5): 1735-1742. doi: 10.1016/S0002-9440(10)64450-1.
9. Hirota WK, Zuckerman MJ, Adler DG, Egan J, Leighton JA, Qureshi WA et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest. Endosc. 2006; 63(4): 570-580. doi: 10.1016/j.gie.2006.02.004.
10. El Hajj II, Hawchar M, Soweid A, Maasri K, Tawil A, Barada KA et al. Giant sporadic fundic gland polyp: endoscopic and endosonographic features and management. World J Gastroenterol. 2008;14(42):6593-6595. doi: 10.3748/wjg.14.6593
11. Spiegel A, Stein P, Patel M, Patel R, Lebovics E. A report of gastric fundic gland polyps. Gastroenterology & Hepatology. 2010; 6(1): 45-48. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886442/pdf/GH-06-45.pdf
12. Raghunath AS, O’Morain C, McLoughlin RC. Review article: the longterm use of proton-pump inhibitors. Aliment. Pharmacol. Ther. 2005; 2(1): 55-63. doi: 10.1111/j.1365-2036.2005.02611.x.
13. Jalving M, Koornstra JJ, Wesseling J, Boezen HM, DE Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006; 24(9): 1341-1348. doi: 10.1111/j.1365-2036.2006.03127.x.
14. Choudhry U, Boyce HW, Coppola JrD. Proton pump inhibitor associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol. 1998; 110(5): 615-621.
15. Cats A, Schenk BE, Bloemena E, Roosedaal R, Lindeman J, Biemond I et al. Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol. 2000; 31(6): 684-690. doi: https://doi.org/10.1053/hupa.2000.7637.
16. Burt R. Clinical management of gastric fundal gland polyps. Gastroenterology. 2003; 125(5): 1462-1469. doi: https://doi.org/10.1016/j.gastro.2003.07.017
17. Bianchi LK, Burke CA, Bennett AE, Lopez R, Hasson H, Church JM. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin. Gastroenterol. Hepatol. 2008; 6(2): 180-185. doi: 10.1016/j.cgh.2007.11.018.
18. Liu WZ, Xie Y, Cheng H, Lu NH, Hu FL, Zhang WD et al. Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection J Dig Dis. 2013;14(6):211-221. doi: 10.1111/1751-2980.12034.
19. Lam-Himlin D, Arnold CA, De Petris G. Gastric polyps and polyposis syndromes. Diagnostic Histopathology. 2013; 2(20): 1-11. doi: https://doi.org/10.1016/j.mpdhp.2013.12.002.
20. Hizawa K, Iida M, Yao T, Aoyagi K, Fujishima M. Juvenile polyposis of the stomach: clinicopathological features and its malignant potential. J Clin Pathol. 1997; 50(9): 771-774.
21. Beggs AD, Latchford AR, Vasen HFA, Moslein G, Alonso A, Aretz S. Peutze-Jeghers syndrome: a systematic review and recommendations for management. Gut. 2010; 59(7): 975-986. doi: 10.1136/gut.2009.198499.
22. Uppal S, Mistry D, Coatesworth AP. Cowden disease: a review. Int J Clin Pract. 2007; 61:645-652. doi: 10.1111/j.1742-1241.2006.00896.x.
23. Vasen H F, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008; 57(5):704-713. doi:10.1136/gut.2007.136127.
24. Samoha S, Arber N. Cronkhite-Canada syndrome. Digestion. 2005; 71(4): 199-200. doi: 10.1159/000086134.
25. Yi SY. Dyslipidemia and H. pylori in gastric xanthomatosis. World J Gastroenterol 2007; 13(34): 4598-4601. doi: 10.3748/wjg.v13.i34.4598.
26. Ormarsson OT, Gudmundsdottir I, Marvik R. Diagnosis and treatment of gastric heterotopic pancreas. World J Surg. 2006; 30(9): 1682-1689. doi: 10.1007/s00268-005-0669-6.
27. Alberti D, Grazioli L, Orizio P, Matricardi L, Dughi S, Gheza L et al. Asymptomatic giant gastric lipoma: What to do? Am J Gastroenterol. 1999; 94(12):3634-36347. doi: 10.1111/j.1572-0241.1999.01391.x.
28. Shaib YH, Rugge M, Graham DY, Genta RM. Management of gastric polyps: an endoscopy-based approach. Clin gastroenterol hepatol. 2013; 11(11):1374-1384. doi: 10.1016/j.cgh.2013.03.019.
2. Carmack SW, Genta RM, Graham DY, Lauwers GY. Management of gastric polyps: a pathologybased guide for gastroenterologists. Nat. Rev. Gastroenterol. Hepatol. 2009; 6(6): 331-341. doi: 10.1038/nrgastro.2009.70.
3. Yamada S, Ichikawa H. Endoscopic characteristics of epithelial gastric polyps. J Gastroenterol. 1966; 6(5): 132-654.
4. Goddard AF, Badreldin R, Pritchard DM, Walker MM, Warren B; British Society of Gastroenterology. The management of gastric polyps. Gut 2010; 59(9): 1270-1276. doi: 10.1136/gut.2009.182089.
5. Аруин Л.И., Капуллер Л.Л., Исаков В.А. Морфологическая диагностика болезней желудка и кишечника. М.: «Триада-Х»; 1998: 496 с.
6. Hiroyoshi O, Riddell R. Gastric Adenoma: Reclassification based on phenotypes and its clinical and diagnostic significance. Pathology case reviews. 2008; 13(5): 189-198. doi: 10.1097/PCR.0b013e318186ac12.
7. Vieth M, Kushima R, Borchard F, Stolte M. Pyloric gland adenoma: a clinicopathological analysis of 90 cases. Virchows Arch. 2003; 442(4): 317-321. doi: 10.1007/s00428-002-0750-6.
8. Abraham SC, Park SJ, Mugartegui L, Hamilton SR, Wu TT. Sporadic fundic gland polyps with epithelial dysplasia: evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Pathol. 2002; 161(5): 1735-1742. doi: 10.1016/S0002-9440(10)64450-1.
9. Hirota WK, Zuckerman MJ, Adler DG, Egan J, Leighton JA, Qureshi WA et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest. Endosc. 2006; 63(4): 570-580. doi: 10.1016/j.gie.2006.02.004.
10. El Hajj II, Hawchar M, Soweid A, Maasri K, Tawil A, Barada KA et al. Giant sporadic fundic gland polyp: endoscopic and endosonographic features and management. World J Gastroenterol. 2008;14(42):6593-6595. doi: 10.3748/wjg.14.6593
11. Spiegel A, Stein P, Patel M, Patel R, Lebovics E. A report of gastric fundic gland polyps. Gastroenterology & Hepatology. 2010; 6(1): 45-48. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886442/pdf/GH-06-45.pdf
12. Raghunath AS, O’Morain C, McLoughlin RC. Review article: the longterm use of proton-pump inhibitors. Aliment. Pharmacol. Ther. 2005; 2(1): 55-63. doi: 10.1111/j.1365-2036.2005.02611.x.
13. Jalving M, Koornstra JJ, Wesseling J, Boezen HM, DE Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006; 24(9): 1341-1348. doi: 10.1111/j.1365-2036.2006.03127.x.
14. Choudhry U, Boyce HW, Coppola JrD. Proton pump inhibitor associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol. 1998; 110(5): 615-621.
15. Cats A, Schenk BE, Bloemena E, Roosedaal R, Lindeman J, Biemond I et al. Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol. 2000; 31(6): 684-690. doi: https://doi.org/10.1053/hupa.2000.7637.
16. Burt R. Clinical management of gastric fundal gland polyps. Gastroenterology. 2003; 125(5): 1462-1469. doi: https://doi.org/10.1016/j.gastro.2003.07.017
17. Bianchi LK, Burke CA, Bennett AE, Lopez R, Hasson H, Church JM. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin. Gastroenterol. Hepatol. 2008; 6(2): 180-185. doi: 10.1016/j.cgh.2007.11.018.
18. Liu WZ, Xie Y, Cheng H, Lu NH, Hu FL, Zhang WD et al. Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection J Dig Dis. 2013;14(6):211-221. doi: 10.1111/1751-2980.12034.
19. Lam-Himlin D, Arnold CA, De Petris G. Gastric polyps and polyposis syndromes. Diagnostic Histopathology. 2013; 2(20): 1-11. doi: https://doi.org/10.1016/j.mpdhp.2013.12.002.
20. Hizawa K, Iida M, Yao T, Aoyagi K, Fujishima M. Juvenile polyposis of the stomach: clinicopathological features and its malignant potential. J Clin Pathol. 1997; 50(9): 771-774.
21. Beggs AD, Latchford AR, Vasen HFA, Moslein G, Alonso A, Aretz S. Peutze-Jeghers syndrome: a systematic review and recommendations for management. Gut. 2010; 59(7): 975-986. doi: 10.1136/gut.2009.198499.
22. Uppal S, Mistry D, Coatesworth AP. Cowden disease: a review. Int J Clin Pract. 2007; 61:645-652. doi: 10.1111/j.1742-1241.2006.00896.x.
23. Vasen H F, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008; 57(5):704-713. doi:10.1136/gut.2007.136127.
24. Samoha S, Arber N. Cronkhite-Canada syndrome. Digestion. 2005; 71(4): 199-200. doi: 10.1159/000086134.
25. Yi SY. Dyslipidemia and H. pylori in gastric xanthomatosis. World J Gastroenterol 2007; 13(34): 4598-4601. doi: 10.3748/wjg.v13.i34.4598.
26. Ormarsson OT, Gudmundsdottir I, Marvik R. Diagnosis and treatment of gastric heterotopic pancreas. World J Surg. 2006; 30(9): 1682-1689. doi: 10.1007/s00268-005-0669-6.
27. Alberti D, Grazioli L, Orizio P, Matricardi L, Dughi S, Gheza L et al. Asymptomatic giant gastric lipoma: What to do? Am J Gastroenterol. 1999; 94(12):3634-36347. doi: 10.1111/j.1572-0241.1999.01391.x.
28. Shaib YH, Rugge M, Graham DY, Genta RM. Management of gastric polyps: an endoscopy-based approach. Clin gastroenterol hepatol. 2013; 11(11):1374-1384. doi: 10.1016/j.cgh.2013.03.019.